Internal Medicine, Cardiovascular Disease · Augusta, GA
NPI
1396787321
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
818 Saint Sebastian Way, Suite 311
Augusta, GA, 30901
Phone (706) 724-3473
Groups this clinician bills Medicare through
Medicare paid, 2024
$154K
3,049 services
Medicare patients, 2024
1,565
Average age 76
Drug cost, 2024
$1.6M
8,399 prescriptions
Company payments, 2025
$689
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kellie V Lane was code 93010 (electrocardiogram), 722 times for 642 patients. In total Kellie V Lane billed 3,049 services in 55 codes, and Medicare paid $154K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-11-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93010 Electrocardiogram | Facility | 722 | 642 | $6.24 | $4,503 |
| 99214 Office E&M - Established | Office | 577 | 484 | $86.90 | $50K |
| 93306 Echocardiography (TTE/TEE) | Facility | 397 | 389 | $49.78 | $20K |
| 93000 Electrocardiogram | Office | 270 | 251 | $10.60 | $2,863 |
| 93018 Electrocardiogram | Facility | 134 | 134 | $10.29 | $1,379 |
| 99232 Hospital E&M - Subsequent | Facility | 130 | 83 | $59.70 | $7,761 |
| 78452 Myocardial Perfusion Scan | Facility | 130 | 130 | $55.63 | $7,231 |
| 99222 Hospital E&M - Initial | Facility | 71 | 71 | $100.20 | $7,115 |
| J2785 Injection, regadenoson, 0.1 mg | Office | 65 | 17 | $6.66 | $433 |
| 99204 Office E&M - New | Office | 54 | 54 | $110.72 | $5,979 |
| 93016 Electrocardiogram | Facility | 42 | 42 | $15.33 | $644 |
| 99213 Office E&M - Established | Office | 41 | 40 | $57.90 | $2,374 |
| 93308 Echocardiography (TTE/TEE) | Facility | 33 | 33 | $18.49 | $610 |
| 99223 Hospital E&M - Initial | Facility | 32 | 32 | $130.43 | $4,174 |
| 92960 Cardiovascular | Facility | 29 | 24 | $79.77 | $2,313 |
By year: 2022 $151K for 2,197 services; 2023 $152K for 2,196 services; 2024 $154K for 3,049 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kellie V Lane prescribed most often to Medicare patients was Metoprolol Succinate, with 619 prescriptions and refills. In total Kellie V Lane wrote 8,399 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 619 | 1,635 | 195 | $8,988 |
| Eliquis Apixaban | 570 | 956 | 136 | $546K |
| Rosuvastatin Calcium Generic | 500 | 1,408 | 147 | $6,586 |
| Flecainide Acetate Generic | 291 | 708 | 77 | $12K |
| Ezetimibe Generic | 220 | 561 | 57 | $3,876 |
| Nebivolol Hcl Generic | 210 | 502 | 61 | $11K |
| Xarelto Rivaroxaban | 205 | 368 | 39 | $204K |
| Telmisartan Generic | 203 | 534 | 66 | $5,804 |
| Amlodipine Besylate Generic | 190 | 456 | 60 | $725 |
| Clopidogrel Clopidogrel Bisulfate | 186 | 509 | 65 | $2,549 |
| Amiodarone Hcl Generic | 179 | 370 | 57 | $2,321 |
| Repatha Sureclick Evolocumab | 169 | 311 | 38 | $179K |
| Sotalol Sotalol Hcl | 163 | 370 | 40 | $2,750 |
| Entresto Sacubitril/Valsartan | 162 | 239 | 28 | $157K |
| Atorvastatin Calcium Generic | 161 | 457 | 50 | $1,807 |
Brand drugs: 1,668 claims; generic drugs: 6,731 claims; opioid claims: 67.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kellie V Lane $689 ($689 in general payments such as food, travel and fees) from 10 companies. The largest payer was Pfizer Inc. with $152.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 8 | $152 |
| Boston Scientific Corporation BSX | 1 | $146 |
| Novo Nordisk Inc NVO | 4 | $96.42 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $67.7 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $64.16 |
| Edwards Lifesciences Corporation EW | 2 | $43.72 |
| Merck Sharp & Dohme LLC MRK | 2 | $37.81 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $32.45 |
| Amgen Inc. AMGN | 2 | $30.65 |
| GlaxoSmithKline, LLC. GSK | 1 | $18.7 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.